| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JCB.26004 |
| P698 | PubMed publication ID | 28332225 |
| P50 | author | Dr.R. Rajesh Kannan | Q67243304 |
| Carlton Ranjith Wilson Alphonse | Q87642823 | ||
| P2093 | author name string | Nagarajan Nagasundaram | |
| Prakash Vincent Samuel Gnana | |||
| P2860 | cites work | The anaplastic lymphoma kinase in the pathogenesis of cancer | Q37039605 |
| The response of T4 lysozyme to large-to-small substitutions within the core and its relation to the hydrophobic effect. | Q42126112 | ||
| ProTox: a web server for the in silico prediction of rodent oral toxicity | Q42724472 | ||
| Modeling cellular signaling: taking space into the computation | Q43088365 | ||
| Computational prediction of neural progenitor cell fates. | Q43169800 | ||
| Predicting HIV drug resistance with neural networks | Q44260439 | ||
| Enhanced prediction of lopinavir resistance from genotype by use of artificial neural networks | Q44559541 | ||
| Predicting bacterial community assemblages using an artificial neural network approach | Q44729654 | ||
| An improved united atom force field for simulation of mixed lipid bilayers. | Q51798189 | ||
| Structure-based methods for predicting target mutation-induced drug resistance and rational drug design to overcome the problem | Q26829549 | ||
| The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non-Small Cell Lung Cancer | Q27682565 | ||
| Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer | Q27851410 | ||
| EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer | Q27851440 | ||
| Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer | Q27851588 | ||
| EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors. | Q27851590 | ||
| The neuroblastoma-associated F1174L ALK mutation causes resistance to an ALK kinase inhibitor in ALK-translocated cancers | Q27851591 | ||
| ALK mutations conferring differential resistance to structurally diverse ALK inhibitors. | Q27851672 | ||
| GROMACS: fast, flexible, and free | Q27860998 | ||
| Response of a protein structure to cavity-creating mutations and its relation to the hydrophobic effect | Q28292427 | ||
| Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties | Q28842810 | ||
| The missing term in effective pair potentials | Q29542481 | ||
| Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer | Q29547564 | ||
| AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility | Q29547658 | ||
| SNPs, protein structure, and disease. | Q30328103 | ||
| Computer prediction of drug resistance mutations in proteins. | Q30350484 | ||
| Selection criteria for drug-like compounds | Q30901599 | ||
| Updated Evidence on the Mechanisms of Resistance to ALK Inhibitors and Strategies to Overcome Such Resistance: Clinical and Preclinical Data | Q30966026 | ||
| Structural and functional restraints on the occurrence of single amino acid variations in human proteins | Q33532646 | ||
| Towards a structural basis of human non-synonymous single nucleotide polymorphisms | Q33899435 | ||
| Diversity and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotype | Q34032267 | ||
| How many ionizable groups can sit on a protein hydrophobic core? | Q34035641 | ||
| Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK. | Q34938204 | ||
| Geno2pheno: Estimating phenotypic drug resistance from HIV-1 genotypes | Q35208107 | ||
| Arpeggio: A Web Server for Calculating and Visualising Interatomic Interactions in Protein Structures | Q36222714 | ||
| P433 | issue | 10 | |
| P921 | main subject | crizotinib | Q5186964 |
| P304 | page(s) | 3462-3471 | |
| P577 | publication date | 2017-05-18 | |
| P1433 | published in | Journal of Cellular Biochemistry | Q6294917 |
| P1476 | title | Molecular Dynamics Validation of Crizotinib Resistance to ALK Mutations (L1196M and G1269A) and Identification of Specific Inhibitors | |
| P478 | volume | 118 |
Search more.